Use of a COPD care pathway heightened the odds for a pulmonary rehabilitation referral and home discharge in hospitalized ...

Mid Yorkshire Teaching NHS Trust has become the first site in Europe to recruit a patient to a major international clinical ...

COPD is no longer solely a smoker's illness. Urban pollution, indoor cooking smoke, and even genetics contribute to rising ...

Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...

A tool combining CV risk score (CVRS) and coronary artery calcium score (CACS) facilitates stratification of patients with COPD at risk for MACE.

Chronic obstructive pulmonary disease is frequently associated with cardiovascular, metabolic, and psychological diseases, all of which can negatively impact quality of life, exacerbations, and ...

Patients hospitalized for acute COPD exacerbation had reduced odds for in-hospital mortality if they had a prior history of bariatric surgery, according to data presented at the CHEST Annual Meeting.“ ...

Temple Health leads research showing how women and non-smokers face rising risks, and how new treatments are changing the ...

Your patients with chronic obstructive pulmonary disease (COPD) may need help not just coping with their condition but also managing it in their workplace. The symptoms of COPD, a lung and airway ...

Biologic therapies targeting eosinophilic inflammation hold promise for COPD management. Realising their benefits will ...

Adequate management of COPD is important because hospitalisation for an acute exacerbation of COPD (AECOPD) is associated ...